Publications:36
Kimberly B Glazer, PhD
About Me
Dr. Glazer's work integrates perinatal epidemiology and obstetric health services research to inform clinical practice and quality improvement across the pregnancy-postpartum continuum. She is experienced in study design and analysis, including the use of population-based, administrative databases to analyze perinatal care quality and outcomes. She has core research interests in (1) classification of obstetric risk, specifically for maternal obesity and impact on labor dysfynction, (2) the use/uptake of evidence-based perinatal interventions, particularly in the context of health disparities, and (3) implementation science and shared decision-making.
Language
English
Position
ASSISTANT PROFESSOR | Obstetrics, Gynecology and Reproductive Science, ASSISTANT PROFESSOR | Population Health Science and Policy
Research Topics
Epidemiology, Global Health, Health Services Research, OBGYN, Obesity, Public Health
Education
BS, Georgetown University
MPH, Columbia University
PhD, Brown University
Publications
Selected Publications
- Characterizing labor progression and duration according to maternal body mass index. Sara E. Edwards, Rebecca Cohen, Zhan Zhao, Raina Kishan, Morgan Steelman, Angela Bianco, Katharine McCarthy, Kimberly B. Glazer, Chelsea A. DeBolt. American Journal of Obstetrics and Gynecology
- Examining the role of neighborhood-level sociostructural indices in predicting spontaneous preterm birth in the New York City metropolitan area. Daniel L. Kuhr, Nicola F. Tavella, Zahava P. Michaelson, Raina Kishan, Nicole Parkas, Rebecca M. Cohen, Chelsea A. DeBolt, Helen Feltovich, Kimberly B. Glazer. American Journal of Obstetrics and Gynecology MFM
- Understanding Postpartum Hospital Use Among Birthing People With Medicaid Insurance. Sarah M. Lindley, Kimberly B. Glazer, Teresa Janevic, Molly Passarella, Angelina Malenda, Natalia N. Egorova, Jennifer Zeitlin, Scott A. Lorch, Elizabeth A. Howell. Obstetrics and Gynecology
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Glazer has not yet completed reporting of industry relationships or has no industry relationships to report.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.